A Kantian analysis of embryonic stem cell research
National Catholic Bioethics Quarterly 2007 Summer; 7(2): 257-262
Stem cell research is undeniably valuable and has generated excitement in the scientific community because of its potential use in developing new therapeutic treatments for chronic and debilitating diseases. Many researchers believe that the development of new human embryonic stem cell (hESC) lines is necessary for success in this research forum. A review of hESC research based on the four principles of biomedical ethics autonomy, beneficence, nonmaleficence, and justice reveals areas of ethical conflict. Specifically, the ethical principles of beneficence and nonmaleficence conflict with the destruction of human embryos in hESC research. Two other ethical approaches that may also be used to evaluate hESC research are the utilitarian and Kantian perspectives. Human embryonic stem cell research demonstrates a divergence from morality because persons (embryos) are treated as means rather than as ends in themselves. Using adult stem cells for research is a viable option that does not pose ethical concerns and yet answers the duty of beneficence that a moral obligation to humanity demands.
Showing items related by title, author, creator and subject.
Oversight framework over oocyte procurement for somatic cell nuclear transfer: comparative analysis of the Hwang Woo Suk case under South Korean bioethics law and U.S. guidelines for human embryonic stem cell research. Kim, Mi-Kyung (2009)We examine whether the current regulatory regime instituted in South Korea and the United States would have prevented Hwang's potential transgressions in oocyte procurement for somatic cell nuclear transfer, we compare the ...
A bill to provide increased Federal funding for stem cell research, to expand the number of embryonic stem cell lines available for Federally funded research, to provide ethical guidelines for stem cell research, to derive human pluripotent stem cell lines using techniques that do not create an embryo or embryos for research or knowingly harm embryos, and for other purposes United States. Congress. Senate (2007-01-23)